Most Recent
Investment firm WAM Active sued by largest shareholder Keybridge
Keybridge Capital has sued WAM Active seeking declarations that a meeting of shareholders in the Wilson Asset Management subsidiary was validly held and a resolution appointing Keybridge's Nicholas Bolton to its board was passed and effective.
Knives come out in Nuix class action beauty parade
A victor remains to be crowned following a heated beauty parade between competing class actions against tech company Nuix, with two law firms facing criticism for their "cumbrous" consolidation proposal and a third firm copping flak for its "opaque" financials.
Quintis investors to get $4.7M in class action settlement, court told
Two years after an insurance dispute scuttled a proposed settlement, group members in two class actions against sandalwood producer Quintis are set to receive $4.7 million in a settlement with the defunct company.
ASIC wins contested extension in Mayfair, Mawhinney appeals
A judge has granted ASIC a hotly contested extension of time in appeals brought by  Mayfair Group and founder James Mawhinney after a judge slapped the investment group with a $30 million penalty.
Law firm seeks 30% cut in EML shareholder class action
The law firm that's running a shareholder class action against payment processing company EML will seek a group costs order for a 30 per cent cut of the suit's proceeds.
Sims settles shareholder class action for $29.5M
Recycling company Sims Limited will pay $29.5 million to settle a shareholder class action alleging earnings guidance for FY16 failed to account for the likely prospect of falling scrap metal prices.
Prosecutors secure second guilty plea in Nova Minerals market manipulation case
NSW man Benjamin Cooper has pleaded guilty to manipulating the share price of Nova Minerals in a conspiracy that involved the gold ore mining company's former CEO.
Class action should foot the bill for first ever group costs order, judge says
A judge who ordered the first ever group costs order in a class action has found that the costs of the application should be borne by the class action.
Mesoblast hit with second shareholder class action over COVID-19 drug
Regenerative medicine company Mesoblast has been hit with a second class action for allegedly misleading shareholders about it Remestemcel-L treatment for COVID-19 complications.
ASIC wins guilty plea from investor who posted about ‘fun and games’ of market manipulation
A Melbourne investor who posted in an online forum that a pump and dump scheme was all part of the “fun and games and cat and mouse of the stock market” has pleaded guilty to market manipulation.